Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease

Journal of Managed Care & Specialty Pharmacy
Sandhya MehtaWilliam K Mountford

Abstract

Multiple studies have reported that type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular diseases (CVD), and presence of T2DM and CVD increases risk of death. There is growing interest in examining the effects of antidiabetic treatments on the reduction of cardiovascular events in T2DM adults with a history of CVD and thus at higher risk of cardiovascular events. To estimate the incremental all-cause health care utilization and costs among adults with T2DM and a history of CVD compared with adults without a history of CVD, using a national linked electronic medical records (EMR) and claims database. Adults aged ≥ 18 years with evidence of at least 1 T2DM-related diagnosis code or antidiabetic medication (date of earliest occurrence was defined as the index date) in calendar year 2012 were identified. The population was divided into 2 cohorts (with and without a history of CVD) and followed until the end of their enrollment coverage, death, or 12 months, whichever came first. Multivariable generalized linear models were used to assess differences in health care utilization and per patient per month (PPPM) total costs (plan- and patient-paid amount for health care services) between the 2 groups during the pos...Continue Reading

References

Oct 1, 1994·Journal of Clinical Epidemiology·H Glauber, J Brown
Apr 17, 2001·Hypertension·J R SowersE D Frohlich
May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Jul 24, 2002·Diabetologia·R WilliamsUNKNOWN CODE-2 Advisory Board
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Mar 1, 2003·Diabetes Care·Paul HoganUNKNOWN American Diabetes Association
Apr 17, 2003·European Journal of Clinical Pharmacology·K E BennettJ Feely
Mar 1, 2006·Diabetes Care·John D Piette, Eve A Kerr
Mar 3, 2007·Journal of Diabetes and Its Complications·Reema ModyVivek Pawar
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Mar 2, 2010·Reviews in Endocrine & Metabolic Disorders·Miguel A ArizaJames L Rosenzweig
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Jan 18, 2012·Cardiovascular Diabetology·Michael E Cobble, Robert Frederich
Mar 8, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Dec 20, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jul 8, 2015·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Dec 18, 2015·Circulation·UNKNOWN Writing Group MembersUNKNOWN Stroke Statistics Subcommittee

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.